Skip to contentB
biote Corp.
B
BTMDbiote Corp. Q2 2024 · 10-Q
Revenue$49.17M$49.17M−0.2% vs Q2 2023 Net Income-$7.09M-$7.09MN/M vs Q2 2023 EPS Diluted-$0.21-$0.21N/M vs Q2 2023 Operating Income$6,233,000−18.7% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
biote Corp. · CIK 1819253 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$7,441,000+9.9% Margins · derivedOperating margin12.7%−2.9 pt vs Q2 2023
Net margin-14.4%−4.0 pt vs Q2 2023
ended Jun 30, 2024 · filed Aug 9, 2024 · 40 d after period end